Increased efficacy of μ-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (−)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959)
- 8 April 2008
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 198 (2) , 271-278
Abstract
Recent experimental data suggest that metabotropic glutamate receptor (mGluR) antagonists with selectivity for mGluR1 and mGluR2/3 enhance morphine-induced antinociception. The present study addressed the hypothesis that mGluR antagonists enhance opioid antinociception by increasing opioid efficacy. The antinociceptive effects of the partial μ-opioid receptor agonists buprenorphine and dezocine were first assessed in a hot-plate procedure under conditions of low (53°C) and high (56°C) stimulus intensity. Under conditions in which buprenorphine and dezocine produced submaximal antinociceptive effects, these drugs were assessed after pretreatment with the mGluR1 antagonist JNJ16259685, the mGluR5 antagonist MPEP, the mGluR2/3 antagonist LY341495, and for comparison, the N-methyl-D-aspartate (NMDA) receptor antagonist LY235959. Buprenorphine (0.032–3.2 mg/kg) and dezocine (0.1–10 mg/kg) were fully efficacious at 53°C and produced submaximal antinociceptive effects at 56°C (i.e., their effects did not exceed 50% of the maximum possible effect). Pretreatment with JNJ16259685 (1.0–3.2 mg/kg), LY341495 (1.0–3.2 mg/kg), and LY235959 (0.32–1.0 mg/kg) enhanced the antinociceptive effects of buprenorphine and dezocine at 56°C, as revealed by significant increases in the peak effects of both drugs to ~100% maximum possible effect. In contrast, pretreatment with MPEP (1.0–3.2 mg/kg) did not modulate the antinociceptive effects of buprenorphine and dezocine. These results suggest that, similar to the NMDA receptor antagonist LY235959, the mGluR1 antagonist JNJ16259685 and the mGluR2/3 antagonist LY341495 increase the antinociceptive efficacy of buprenorphine and dezocine.Keywords
This publication has 29 references indexed in Scilit:
- Morphine in Combination with Metabotropic Glutamate Receptor Antagonists on Schedule-Controlled Responding and Thermal NociceptionThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Interactions between an N-Methyl-D-aspartate Antagonist and Low-Efficacy Opioid Receptor Agonists in Assays of Schedule-Controlled Responding and Thermal NociceptionThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Dextromethorphan differentially affects opioid antinociception in ratsBritish Journal of Pharmacology, 2005
- Modulation of morphine analgesia by site-specific N -methyl-d-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and timePain, 2004
- An Examination of the Interactions Between the Antinociceptive Effects of Morphine and Various [micro sign]-OpioidsAnesthesia & Analgesia, 1999
- Dual Action of Metabotropic Glutamate Receptor Agonists on Neuronal Excitability and Synaptic Transmission in Spinal Ventral Horn Neurons In VitroNeuropharmacology, 1996
- Pharmacology of metabotropic glutamate receptor-mediated enhancement of responses to excitatory and inhibitory amino acids on rat spinal neurones in vivoNeuropharmacology, 1995
- Abuse liability studies of opioid agonist-antagonists in humansDrug and Alcohol Dependence, 1991
- Opioid Agonist-Antagonist Drugs in Acute and Chronic Pain StatesDrugs, 1991
- Approaches to the study of drug interactions in behavioral pharmacologyNeuroscience & Biobehavioral Reviews, 1986